NCI-LED RESEARCH TEAM DEVELOPS PREDICTOR FOR IMMUNOTHERAPY RESPONSE IN MELANOMA

Researchers have developed a way to predict which patients with melanoma are likely to respond to immunotherapy drugs known as checkpoint inhibitors. To read the full article, click the image below.